Explosive Buying, Drug Quality And Premier Li
This article was originally published in PharmAsia News
Executive Summary
Reports of Chinese tourists flocking to Japanese drug stores and buying up everything from cold remedies to Band-Aids seems to have caught the eye of Premier Li Keqiang, who in a Feb. 14 Cabinet meeting outlined a number of broad-brush policies to stimulate the pharma industry to improve quality and meet public health care needs.
You may also be interested in...
2016 Review: Rapid Change Defines China Regulatory Environment
If you missed some of the many significant events in China’s policy and regulatory landscape in 2016, here is your opportunity to catch up on month-by-month developments.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.
Chinese Language Podcast: BIOSECURE Act, US PD-1 Approval, ADC Updates
Guest speaker and lawyer Kevin Duan joins Brian Yang and Dexter Yan to discuss the planned US BIOSECURE Act, the US approval of BeiGene's anti-PD-1 drug and the latest antibody-drug conjugates in development at Chinese pharma firms.